Overview
Jennifer Gannon is a Pediatrics specialist and a Medical Genetics provider in Kansas City, Missouri. Dr. Gannon is rated as an Experienced provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are Phenylketonuria (PKU), Maternal Hyperphenylalaninemia, Dihydropteridine Reductase Deficiency, and Propionic Acidemia. Dr. Gannon is currently accepting new patients.
Her clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2401 Gillham Rd, Kansas City, MO 64108
5808 W 110th St, Overland Park, KS 66211
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Bryce Heese is a Medical Genetics specialist and a Pediatrics provider in Kansas City, Missouri. Dr. Heese is rated as a Distinguished provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Chromosome 6q Deletion, Phenylketonuria (PKU), Dihydropteridine Reductase Deficiency, and Maternal Hyperphenylalaninemia. Dr. Heese is currently accepting new patients.
Helena Laroche is a primary care provider, practicing in Pediatrics and Internal Medicine in Kansas City, Missouri. Dr. Laroche is rated as an Advanced provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are Obesity, Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Obesity in Children, and Metabolic Syndrome. Dr. Laroche is currently accepting new patients.
Nasreen Noor is a Pediatrics specialist and an Intensive Care Medicine provider in Kansas City, Missouri. Dr. Noor is rated as an Experienced provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top area of expertise is Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Dihydropteridine Reductase Deficiency
- Maternal HyperphenylalaninemiaDr. Gannon isAdvanced. Learn about Maternal Hyperphenylalaninemia.
- Phenylketonuria (PKU)Dr. Gannon isAdvanced. Learn about Phenylketonuria (PKU).
- Experienced
- AspartylglucosaminuriaDr. Gannon isExperienced. Learn about Aspartylglucosaminuria.
- Danon DiseaseDr. Gannon isExperienced. Learn about Danon Disease.
- Krabbe DiseaseDr. Gannon isExperienced. Learn about Krabbe Disease.
- Mucopolysaccharidoses (MPS)Dr. Gannon isExperienced. Learn about Mucopolysaccharidoses (MPS).
- Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)